Federal Register / Vol. 85, No. 245 / Monday, December 21, 2020 / Notices 83099 

and scientific organizations, and public 

organizations. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating, and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Average 

number of 

responses per 

respondent 

Total 

number of 

responses 

Average 

burden per 

response 

(in minutes) 

Total 

burden 

hours 

Potential Living Donor Registration form ............................. a 16 112 1,792 .27 484 

Potential Living Donor Follow-up form ................................ b 754 1 754 .50 377 

Reasons Did not Donate form (liver or kidney) ................... a 16 106 1,696 .23 390 

Total .............................................................................. 786 ........................ 4,242 ........................ 1,251 

a Number of respondents is based on the current number of transplant programs and is likely to increase as additional programs decide to participate. b Number of living organ donor candidates submitting follow-up forms in 2019. 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions; (2) the accuracy of the 

estimated burden; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2020–28017 Filed 12–18–20; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the National Vaccine 

Advisory Committee 

AGENCY: Office of Infectious Disease and 

HIV/AIDS Policy, Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) is hereby giving notice 

that the National Vaccine Advisory 

Committee (NVAC) will hold a virtual 

meeting. The meeting will be open to 

the public and public comment will be 

heard during the meeting. 

DATES: The meeting will be held 

February 4–5, 2021. The confirmed 

meeting times and agenda will be 

posted on the NVAC website at http:// 

www.hhs.gov/nvpo/nvac/meetings/ 

index.html as soon as they become 

available. 

ADDRESSES: Instructions regarding 

attending this meeting will be posted 

online at: http://www.hhs.gov/nvpo/ 

nvac/meetings/index.html at least one 

week prior to the meeting. Preregistration is required for those who 

wish to attend the meeting or participate 

in public comment. Please register at 

http://www.hhs.gov/nvpo/nvac/ 

meetings/index.html. 

FOR FURTHER INFORMATION CONTACT: Ann 

Aikin, Acting Designated Federal 

Officer, at the Office of Infectious 

Disease and HIV/AIDS Policy, U.S. 

Department of Health and Human 

Services, Mary E. Switzer Building, 

Room L618, 330 C Street SW, 

Washington, DC 20024. Email: nvac@

hhs.gov. Phone: 202–695–9742. 

SUPPLEMENTARY INFORMATION: Pursuant 

to Section 2101 of the Public Health 

Service Act (42 U.S.C. 300aa–1), the 

Secretary of HHS was mandated to 

establish the National Vaccine Program 

to achieve optimal prevention of human 

infectious diseases through 

immunization and to achieve optimal 

prevention against adverse reactions to 

vaccines. The NVAC was established to 

provide advice and make 

recommendations to the Director of the 

National Vaccine Program on matters 

related to the Program’s responsibilities. 

The Assistant Secretary for Health 

serves as Director of the National 

Vaccine Program. 

During this NVAC meeting, NVAC 

will hear presentations on vaccine 

safety, communication activities for 

COVID–19 vaccines, and immunization 

equity. Please note that agenda items are 

subject to change, as priorities dictate. 

Information on the final meeting agenda 

will be posted prior to the meeting on 

the NVAC website: http://www.hhs.gov/ 

nvpo/nvac/index.html. 

Members of the public will have the 

opportunity to provide comment at the 

NVAC meeting during the public 

comment period designated on the 

agenda. Public comments made during 

the meeting will be limited to three 

minutes per person to ensure time is 

allotted for all those wishing to speak. 

Individuals are also welcome to submit 

written comments in advance. Written 

comments should not exceed three 

pages in length. Individuals submitting 

comments should email their written 

comments or their request to provide a 

comment during the meeting to nvac@

hhs.gov at least five business days prior 

to the meeting. 

Dated: October 27, 2020. 

Ann Aikin, 

Acting Designated Federal Official, Office of 

the Assistant Secretary for Health. 

[FR Doc. 2020–28046 Filed 12–18–20; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Division of Program Coordination, 

Planning, and Strategic Initiatives, 

Office of the Director Notice of 

Proposed Reorganization 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice.